Subscribe


PD breaking news – ACCC to appeal atorvastatin decision

Federal Court dismissed anti-competitive conduct case in February. 

The Australian Competition and Consumer Commission (ACCC) has filed a Notice to Appeal for the Federal Court’s decision to dismiss its anti-competitive conduct case against Pfizer.

The ACCC allegations related to offers made to pharmacies in early 2012 for the supply of Lipitor and Pfizer’s generic atorvastatin product, with the ACCC alleging Pfizer had misused its “substantial market power” and engaged in exclusive dealing conduct for the purpose of substantially lessening competition.

The Federal Court dismissed the case, saying that while Pfizer had taken advantage of its market power with the alleged conduct, this power was no longer substantial at the time of the offers, and that the ACCC had not established that Pfizer had engaged in this conduct to deter or prevent competitive conduct (PD 26 Feb).

ACCC chairman Rod Sims said cases involving allegations of misuse of market power and anti-competitive practices would always be a priority for the organisation.

“It is therefore important that the ACCC seeks clarity from the Full Court on issues of market power and anti-competitive purpose, such as those raised by this case.”

For more, see tomorrow’s Pharmacy Daily.


The above Breaking News Alert was sent to Pharmacy Daily subscribers on 18 Mar 15

Make a comment...



Established in 2007, Pharmacy Daily is Australia's leading pharmacy industry publication, and is sent as a free subscription to people across the industry as a PDF newsletter every weekday.

Register for Pharmacy Daily trial subscription

To sign up for a free subscription, click on the button at right.

Click here to see a sample issue of Pharmacy Daily.

Click here for more information on subscriptions.

Alternatively, you can search our site via the search box on the right hand side of the page, or find other content below.

Recent Pharmacy Daily articles

26 Feb

Weekly Comment 26 Feb 18 - WELCOME to PD's weekly comment feature. This ...


26 Feb

Dispensary Corner 26 Feb 18 - REPRODUCTION experts have long held the view ...


26 Feb

Low BC awareness - A NEW report published in Public Health ...


26 Feb

Champix cardiac link - NEW research published in the American Journal ...


26 Feb

Pharmacy’s future - ALL APP Conference 2018 attendees are being ...


26 Feb

Pharmacy chronic pain - DESPITE protestations by pharmacists that they have ...


26 Feb

APC consultant call - THE Australian Pharmacy Council (APC) is calling ...


26 Feb

FDA beats EMA - FROM 2007 to 2016, the US Food ...


26 Feb

Cannabis claims challenge - CLAIMS that medical cannabis use has reduced ...


26 Feb

Beauty Prescription bash - PRICELINE Pharmacy transformed Sydney's Randwick Racecourse into ...


23 Feb

Dispensary Corner 23 Feb 18 - DEDICATION to the task, what every company ...


23 Feb

J&J choice employer - THE Johnson & Johnson Family of Companies ...


23 Feb

Abstract submissions - CHOOSING Wisely Australia, an NPS MedicineWise initiative ...


23 Feb

Codeine price hike - SINCE products containing codeine became prescription only ...


23 Feb

My Chemist wins Roy Morgan PoTY - AUSTRALIAN pharmacy retailer My Chemist has taken ...


23 Feb

E-cigs support detox - ELECTRONIC cigarettes, used as an alternative form ...


23 Feb

New $35m global Ego HQ - FEDERAL Minister for Health Greg Hunt officially ...


23 Feb

Blackmores profit up 20% - BLACKMORES has reported overall group revenue was ...


23 Feb

MCC on cautionary RACP - AUSTRALIA'S peak medical cannabis industry group, the ...


22 Feb

PD breaking news – Blackmores H1 profit up 20% - Blackmores H1 profit up 20%Blackmores has reported ...



Show Pharmacy Daily items by month: